These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 781924)

  • 1. Lack of demonstrable H-2 antigens on the surface of teratocarcinoma 402AX of the mouse maintained in vivo.
    Isa AM
    Transplantation; 1976 Mar; 21(3):196-8. PubMed ID: 781924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-lymphocyte suppressor activity in the cytotoxic response to the teratocarcinoma 402AX of the mouse.
    Isa AM; Sanders BR; Parham CA
    Transplant Proc; 1977 Mar; 9(1):1167-9. PubMed ID: 301303
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to 402AX teratocarcinoma involves immunity to minor histocompatibility antigens.
    Ostrand-Rosenberg S; Clements V
    Immunogenetics; 1987; 26(1-2):1-5. PubMed ID: 3301646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host mice.
    Ostrand-Rosenberg S; Cohan VL
    J Immunol; 1981 Jun; 126(6):2190-3. PubMed ID: 7229370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN; Florentz K; Güttler F
    Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of histocompatibility antigens on a murine ovarian teratocarcinoma.
    Vanhaelen CP; Fisher RI; Appella E; Ramanathan L
    Cancer Res; 1981 Aug; 41(8):3186-91. PubMed ID: 7018676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivo.
    Ostrand-Rosenberg S; Cohn AL; Sandoz JW
    J Immunol; 1983 Jun; 130(6):2969-73. PubMed ID: 6133895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Origin of effector and rosette-forming cells in transplantation immunity in mice].
    Brondz BD; Kotomina IF
    Biull Eksp Biol Med; 1973 Sep; 76(9):69-72. PubMed ID: 4130411
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the H-2k haplotype.
    Steinmuller D; Tyler JD; David CS
    J Immunol; 1981 May; 126(5):1747-53. PubMed ID: 6452477
    [No Abstract]   [Full Text] [Related]  

  • 10. Serological analysis of H-2 antigens expression on the cell surface of selected mouse tumors.
    Opolski A; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(1):7-17. PubMed ID: 3778116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-41, a new minor histocompatibility locus. I. Histogenetic analysis.
    Juretić A; Vucak I; Malenica B; Nagy ZA; Klein J
    J Immunol; 1984 Dec; 133(6):2950-4. PubMed ID: 6386980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of cell-mediated transplantation reactions. II. Studies with a sensitive assay of cell-mediated cytotoxicity.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):441-55. PubMed ID: 4137937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of murine Ia antigens during embryonic development.
    Delovitch TL; Press JL; McDevitt HO
    J Immunol; 1978 Mar; 120(3):818-24. PubMed ID: 75925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity between HL-A and H-2 antigens. II. Allogeneic sensitization by xenogeneic soluble lymphocyte antigens (HL-A).
    Götze BD; Lee S; Ferrone S; Pellegrino MA; Reisfeld RA
    Transplant Proc; 1973 Mar; 5(1):467-70. PubMed ID: 4572106
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune-response gene control of cytotoxic T-cell responses to H-Y.
    Gordon RD; Simpson E
    Transplant Proc; 1977 Mar; 9(1):885-8. PubMed ID: 301314
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
    Harada M; Pearson G; Pettigrew H; Redmon L; Orr T
    Cancer Res; 1973 Nov; 33(11):2886-93. PubMed ID: 4583975
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic studies and effect on skin allograft survival of DBA-2 DAG, Ly, and M-locus antigens.
    Sachs JA; Huber B; Peña-Martinez J; Festenstein H
    Transplant Proc; 1973 Dec; 5(4):1385-7. PubMed ID: 4590621
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inactivation of allogeneic stem cells by lymphocytes identical as regards the H2 system of tissue compatibility].
    Petrov RV; Egorov IK; Seslavina LS; Panteleev EI; Egorova OS
    Dokl Akad Nauk SSSR; 1974; 219(6):1489-91. PubMed ID: 4155671
    [No Abstract]   [Full Text] [Related]  

  • 19. Inappropriate alloantigen-like specificities detected on reticulum cell sarcomas of SJL/J mice: characterization and biologic role.
    Bonavida B; Roman JM; Hutchinson IV
    Transplant Proc; 1980 Mar; 12(1):59-64. PubMed ID: 6154360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of the presentation of minor lymphocyte stimulating determinants. I. Combined importance of MHC and non-MHC influences.
    Ryan JJ; Mond JJ; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1063-73. PubMed ID: 3135319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.